/Abbott%20Laboratories%20HQ%20photo-%20by%20Sundry%20Photography%20via%20iStock.jpg)
With a market cap of $162.4 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and markets a wide range of pharmaceutical, diagnostic, nutritional, and medical device products worldwide. It operates through four business segments: Established Pharmaceuticals; Diagnostics; Nutrition; and Medical Devices, serving diverse healthcare needs across the globe.
The Abbott Park, Illinois-based company is expected to unveil its fiscal Q2 2026 results before the market opens on Thursday, Jul. 16. Ahead of the event, analysts forecast ABT to post an adjusted EPS of $1.28, a rise of 1.6% from $1.26 in the same quarter last year. It has surpassed or met Wall Street's bottom-line projections in the past four quarters.
